Analysing DNA patents in relation with diagnostic genetic testing

European Journal of Human Genetics

Volumn 14, Issue 1, 2006, Pages 26-33

  Verbeure, Birgit ^a   Matthijs, Gert ^a   Van Overwalle, Geertrui ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

BRCA1; BRCA2; Breast cancer genes; Diagnostic testing; Gene patents

Indexed keywords

APOLIPOPROTEIN E; BRCA1 PROTEIN; BRCA2 PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 3; HFE PROTEIN; TUBERIN;

ACHONDROPLASIA; ALZHEIMER DISEASE; ARTICLE; BREAST CANCER; CANAVAN DISEASE; COLORECTAL TUMOR; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DNA SEQUENCE; GAUCHER DISEASE; GENETIC ANALYSIS; GENETIC DISORDER; HEMOCHROMATOSIS; HUMAN; HUNTINGTON CHOREA; INFORMATION RETRIEVAL; MEDICAL GENETICS; NEUROFIBROMATOSIS; OVARY CANCER; PATENT; PILOT STUDY; PRIORITY JOURNAL; SHORT STATURE; TUBEROUS SCLEROSIS;

ALGORITHMS; BREAST NEOPLASMS; DATABASES, FACTUAL; DIAGNOSTIC TECHNIQUES AND PROCEDURES; DNA; EUROPE; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC DISEASES, INBORN; GENETIC TECHNIQUES; HUMANS; OVARIAN NEOPLASMS; PATENTS;

EID: 29644436864     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201503     Document Type: Article

References (19)

1. Collins FS, Green ED, Guttmacher AE, Guyer MS: A vision for the future of genomics research. Nature 2003; 422: 835-847.
2. Eisenberg RS: Why gene patenting controversy persists. Acad Med 2002; 77 (12): 1381-1387.
3. Rimmer M: Myriad Genetics: Patent Law and Genetic Testing. EIPR 2003; 25: 20-33.
4. Williams-Jones B: History of a Gene Patent: Tracing the Development and Application of Commercial BRCA-Testing. Health Law J 2002; 10: 123-146.
5. Walpole IR, DaTkins HJS, Sinden PD, O'Leary PC: Human gene patents: the possible impacts on genetic services healthcare. Med J Aus 2003; 179: 203-205.
6. Merz JF, Kriss AG, Leonard DGB, Cho MK: Diagnostic testing fails the test. Nature 2002; 415: 577-579.
7. Organisation for Economic Co-operation and Development (OECD): Genetic inventions, intellectual property rights and licensing practices: evidence and policies, 2002, http://www.oecd.org/dataoecd/42/21/ 2491084.pdf.
8. Nuffield council on Bioethics: The ethics of patenting DNA. A discussion Paper, 2002, www.nuffieldbioethics.com.
9. Nicol D: Gene Patents and access to genetic tests. Aus Health Law Bull 2003; 11: 73-77.
10. Straus J, Holzapfel H, Lindenmeir M: Empirical survey on 'Genetic Inventions and Patent Law'; Munich. 2002 commissioned by the Federal Ministry of Education and Research, Germany.
11. Matthijs G, Halley D: European-wide opposition against the breast cancer gene patents. Eur J Hum Gen 2002; 10: 783-784.
12. Cho MK, Illangasekare S, Weaver MA, Leonard DGB, Merz JF: Effects of patents and licenses on the provision of clinical genetic testing services. J Mol Diagnostics 2003; 5: 3-8.
13. Sevilla C, Moatti JP, Julian-Reynier C, Eisinger F, Stoppa-Lyonnet D, Bressac-de Paillerets SA: Testing for BRCA1 mutations: a cost-effectiveness analysis. Eur J Hum Gen 2002; 10: 599-606.
14. Paradise J, AndrewA L, Holbrook T: Patents on human genes: an analysis of scope and claims. Science 2005; 307: 1566-1567.
15. Abbott A: Pressured staff 'lose faith' in patent quality. Nature 2004; 429: 493.
16. Abbott A: Clinicians win fight to overturn patent for breast-cancer gene. Nature 2004; 429: 329.
17. Abbott A: Europe pares down double patents on breast-cancer gene. Nature 2005; 433: 344.
18. Abbott A: Genetic patent singles out Jewish women. Nature 2005; 436: 12.
19. Dalpé R, Bouchard L, Houle AJ, Bédard L: Watching the race to find the breast cancer genes. Sci Technol Human Values 2003; 28: 187-216.